Anxiety-Related Bleeding and Thrombosis

Area of Science:

• Cardiovascular Medicine
• Hematology
• Psychiatry

Background:

• Anxiety triggers procoagulant and fibrinolytic responses, creating a complex hemostatic balance.
• The fight-or-flight response involves increased clotting factors and platelet aggregation, counteracted by tissue plasminogen activator (tPA) release.
• Disturbances in this balance can predispose anxious individuals to bleeding or thrombotic events.

Purpose of the Study:

• To explore the multifactorial pathogenesis of cardiovascular and thrombotic diseases in highly anxious patients.
• To investigate the role of anxiety in modulating hemostasis and its clinical implications.
• To examine the contribution of hypercoagulation, hyperfibrinolysis, and associated conditions to thrombotic risk.

Main Methods:

• Review of existing literature on anxiety, hemostasis, and cardiovascular/thrombotic diseases.
• Analysis of physiological responses to acute mental stress, including clotting factor levels and fibrinolytic activity.
• Examination of the impact of comorbid conditions like depression and hyperinsulinemia on thrombotic risk in anxious individuals.

Main Results:

• Acute anxiety is characterized by increased clotting factors (factor VIII, fibrinogen, von Willebrand factor) and platelet aggregability.
• Mental stress induces tPA release, activating fibrinolysis to counteract procoagulant stimuli.
• Anxiety contributes to cardiovascular risk via α-adrenergic vasoconstriction, increased blood viscosity, hypertension, and plaque instability.
• Overproduction of tPA can paradoxically increase cardiovascular risk by degrading the extracellular matrix and causing vascular stiffness.
• Anxious patients with elevated plasminogen activator inhibitor-1 (PAI-1) levels, often seen in depression or hyperinsulinemia, face a high thrombosis risk.

Conclusions:

• The interplay between hypercoagulation and hyperfibrinolysis in anxiety dictates the risk of bleeding or thrombosis.
• Anxiolytic interventions may help manage bleeding in hemostatic disorders.
• High anxiety, particularly when combined with depression or lifestyle-induced hyperinsulinemia, plays a significant role in the pathogenesis of unprovoked thrombotic events.